<p>Influenza A viruses subvert lysosomal function to evade host degradation mechanisms. Using Connectivity Map (CMap) screening and transcriptomic analysis, we identified fangchinoline (Fan)—a bisbenzylisoquinoline alkaloid—as a potent enhancer of lysosomal gene expression. Owing to its alkaline properties, Fan accumulates within lysosomes, elevates luminal pH, and induces TFEB nuclear translocation, thereby restoring lysosomal biogenesis and initiating a TFEB-driven antiviral response. Concurrently, Fan disrupts autophagosome–lysosome fusion and impairs autophagic flux, further enhancing its antiviral activity. Time-resolved functional assays demonstrate that Fan primarily inhibits H1N1 infection at the entry stage by obstructing endolysosomal trafficking. Together, these results identify Fan as a novel TFEB-mediated lysosomal modulator that antagonizes influenza infection by counteracting viral lysosomal evasion strategies and highlighting the therapeutic potential of lysosome-targeted compounds in influenza treatment.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Fangchinoline restores TFEB-driven lysosomal biogenesis and blocks H1N1 infection

  • Cui-qin Cheng,
  • Fang Xie,
  • Zhe Liu,
  • Jun-liang Li,
  • Yuan-yuan Qiao,
  • Ling-dong Kong,
  • Qi-qi Li,
  • Ke-xin Ma,
  • Fei Liu,
  • Liang-dong Song,
  • Han Wang,
  • Yao Wang,
  • Xin Jia

摘要

Influenza A viruses subvert lysosomal function to evade host degradation mechanisms. Using Connectivity Map (CMap) screening and transcriptomic analysis, we identified fangchinoline (Fan)—a bisbenzylisoquinoline alkaloid—as a potent enhancer of lysosomal gene expression. Owing to its alkaline properties, Fan accumulates within lysosomes, elevates luminal pH, and induces TFEB nuclear translocation, thereby restoring lysosomal biogenesis and initiating a TFEB-driven antiviral response. Concurrently, Fan disrupts autophagosome–lysosome fusion and impairs autophagic flux, further enhancing its antiviral activity. Time-resolved functional assays demonstrate that Fan primarily inhibits H1N1 infection at the entry stage by obstructing endolysosomal trafficking. Together, these results identify Fan as a novel TFEB-mediated lysosomal modulator that antagonizes influenza infection by counteracting viral lysosomal evasion strategies and highlighting the therapeutic potential of lysosome-targeted compounds in influenza treatment.